References
- Akashi A, Kuwano K. (2002) Fas-mediated lysis of target cell by IL-2 treated cytotoxic T lymphocytes. Kurume Med. J. 49, 119-129. https://doi.org/10.2739/kurumemedj.49.119
- Alvarez XA, Pichel V, Perez P, Laredo M, Corzo D, Zas R, Fernandez-Novoa L, Sempere JM, Diaz J, Cacabelos R. (2000) Double-blind, randomized, placebocontrolled pilot study with anapsos in senile dementia: effects on cognition, brain bioelectrical activity and cerebral hemodynamics. Methods Find Exp. Clin. Pharmacol. 22, 585-594.
- Alvarez XA, Franco-Maside A, Zas R, Sempere JM, Diaz J, Cacabelos R. (1997) Anapsos reverses interleukin-1 beta overexpression and behavioral deficits in nbMlesioned rats. Methods Find Exp. Clin. Pharmacol. 19, 299-309.
- Bernd A, Ramirez-Bosca A, Huber H, Diaz Alperi J, Thaci D, Sewell A, Quintanilla Almagro E, Holzmann H (1995) In vitro studies on the immununomodulating effects of polypodium leucotomos extract on human leukocyte fractions. Arzneimittel forschung 45, 901-904.
- Das S, Khar A. (2002) Regulation of NK cell function in vivo by the dose of tumour transplanted in the peritoneum. Immunol. Lett. 83,133-142. https://doi.org/10.1016/S0165-2478(02)00099-8
- De Smet PA. (2002) Herbal remedies. N. Engl. J. Med. 347, 2046-2056. https://doi.org/10.1056/NEJMra020398
- El-Miedany Y. (2002) The evolving therapy of rheumatic diseases, the future is now. Curr. Drug Targets Immune. Endocr. Metabol. Disord 2, 1-11. https://doi.org/10.2174/1568008024606347
- Fernandez-Novoa L, Alvarez XA, Sempere JM, Miguel-Hidalgo JJ, Diaz J, Franco-Maside A, Cacabelos R. (1997) Effects of anapsos on the activity of the enzyme Cu-Zn-superoxide dismutase in an animal model of neuronal degeneration. Methods Find Exp. Clin. Pharmacol. 19, 99-106.
- Ford MS, Young KJ, Zhang Z, Ohashi PS, Zhang L. (2002) The immune regulatory function of lymphoproliferative double negative T cells in vitro and in vivo. J. Exp. Med. 196, 261-267. https://doi.org/10.1084/jem.20020029
- Fujii T. (2002) Herbal factors in the treatment of autoimmunity-related habitual abortion. Vitam. Horm. 65, 333-344. https://doi.org/10.1016/S0083-6729(02)65070-8
- Gomes AJ, Lunardi CN, Gonzalez S, Tedesco AC. (2001) The antioxidant action of Polypodium leucotomos extract and kojic acid: reactions with reactive oxygen species. Braz. J. Med. BioI. Res. 34, 1487-1494. https://doi.org/10.1590/S0100-879X2001001100018
- Haque MA, Mizobuchi T, Yasufuku K, Fujisawa T, Brutkiewicz RR, Zheng Y, Woods K, Smith GN, Cummings OW, Heidler KM, Blum JS, Wilkes DS. (2002) Evidence for immune responses to a selfantigen in lung transplantation: role of type V collagen-specific T cells in the pathogenesis of lung allograft rejection. J. Immunol. 169, 1542-1549. https://doi.org/10.4049/jimmunol.169.3.1542
- Kalunian KC, Davis JC Jr, Merrill JT, Totoritis MC, Wofsy D; IDEC-131 Lupus Study Group. (2002) Treatment of systemic lupus erythematosus by inhibition of T cell costimulation with anti-CDI54: a randomized, double-blind, placebocontrolled trial. Arthritis Rheum. 46, 3251-3258. https://doi.org/10.1002/art.10681
- Krook H, Wennberg L, Hagberg A, Song Z, Groth CG, Korsgren O. (2002) Immunosuppressive drugs in islet xenotransplantation: a tool for gaining further insights in the mechanisms of the rejection process. Transplantation 74, 1084-1089. https://doi.org/10.1097/00007890-200210270-00005
- Kuiper-Geertsma DG, Derksen RH. (2003) Newer drugs for the treatment of lupus nephritis. Drugs 63, 167-80.
- Lazzaro C, McKechnie T, McKenna M. (2002) Tacrolimus versus cycIosporin in renal transplantation in Italy: cost-minimisation and cost-effectiveness analyses. J. Nephrol. 15, 580-588.
- McCutcheon AR, Roberts TE, Gibbons E, Ellis SM, Babiuk LA, Hancock RE, Towers GH. (1995) Antiviral screening of British Columbian medicinal plants. J. Ethnopharmacol. 49, 101-110. https://doi.org/10.1016/0378-8741(95)90037-3
- Pinkoski MJ, Droin NM, Green DR. (2002) Tumor necrosis factor alpha upregulates non-lymphoid Fas-ligand following superantigen-induced peripheral lymphocyte activation. J. BioI. Chem. 277, 42380-42385. https://doi.org/10.1074/jbc.M208167200
- Reynolds NJ, Meggitt SJ. (2002) Phototherapy and systemic treatments. Hosp. Med. 63, 657-661. https://doi.org/10.12968/hosp.2002.63.11.1910
- Reixach N, Lafont R, Camps F, Casas J. (1999) Biotransformations of putative phytoecdysteroid biosynfuetic precursors in tissue cultures of Polypodium vulgare. Eur. J. Biochem. 266, 608-615. https://doi.org/10.1046/j.1432-1327.1999.00905.x
- Saydain G, George L, Raoof S. (2002) New therapies: plasmapheresis, intravenous immunoglobulin, and monoclonal antibodies. Crit. Care. Clin. 18, 957-75. https://doi.org/10.1016/S0749-0704(02)00028-3
- Segel LD, vonHaag DW, Zhang J, Follette DM. (2002) Selective overexpression of inflammatory molecules in hearts from brain-dead rats. J. Heart. Lung. Transplant. 7, 804-811.
- Sempere-Ortells JM, Campos A, Velasco I, Marco F, Ramirez-Bosca A, Diaz J, Pardo J. (2002) Anapsos (Polypodium leucotomos) modulates lymphoid cells and the expression of adhesion molecules. Pharmacol. Res. 46, 185-190. https://doi.org/10.1016/S1043-6618(02)00091-9
- Vasange-Tuominen M, Perera-Ivarsson P, Shen J, Bohlin L, Rolfsen W. (1994) The fern Polypodium decumanum, used in the treatment of psoriasis, and its fatty acid constituents as inhibitors of leukotriene B4 formation. Prostaglandins Leukot Essent Fatty Acids 50, 279-284. https://doi.org/10.1016/0952-3278(94)90167-8
- Vasange M, Liu B, Welch CJ, Rolfsen W, Bohlin L. (1997) The flavonoid constituents of two Polypodium species (Calaguala) and their effect on the elastase release in human neutrophils. Planta. Med. 63,511-517. https://doi.org/10.1055/s-2006-957753
- Vickers A. (2002) Botanical medicines for the treatment of cancer: rationale, overview of current data, and methodological considerations for phase I and II trials. Cancer Invest. 20, 1069-1079. https://doi.org/10.1081/CNV-120005926
- Waller JR, Murphy GJ, Bicknell GR, Toomey D, Nicholson ML. (2002) Effects of the combination of rapamycin with tacrolimus or cyclosporin on experimental intimal hyperplasia. Br. J. Surg. 11, 1390-1395.
- Wigginton JM, Gruys E, Geiselhart L, Subleski J, Komsclies KL, Park JW, Wiltrout TA, Nagashima K, Back TC, Wiltrout RH. (2001) IFN-gamma and Fas/FasL are required for the antitumor and antiangiogenic effects of IL-12/pulse IL-2 therapy. J. Clin. Invest. 108, 51-62. https://doi.org/10.1172/JCI200110128
- Zweifel M, Hirsiger H, Matozan K, Welle M, Schaffner T, Mohacsi P. (2002) Mast cells in ongoing acute rejection: increase in number and expression of a different phenotype in rat heart transplants. Transplantation 73, 1707-1716. https://doi.org/10.1097/00007890-200206150-00004